Protagonist Therapeutics, Inc. (NASDAQ:PTGX) | WebDisclosure

Basculer en Français

10681	Companies
228020	Keywords
156520	Articles
120880	Press releases

Headlines Articles Press releases Protagonist Therapeutics, Inc.

Home
Companies
Protagonist Therapeutics, Inc.

PRESS RELEASE

published on 05/14/2024 at 22:05, 2 years 1 month ago

Protagonist Therapeutics Announces Oral Presentation on Long-Term Follow-up of Rusfertide Phase 2 REVIVE Study Open Label Extension at the European Hematology Association 2024 Congress
Protagonist Therapeutics to present rusfertide Phase 2 REVIVE study data at EHA Congress in Madrid. Study shows absence of QTc prolongation with rusfertide. Details on pipeline drugs and collaborations available on company's website

Clinical Development Collaborations Protagonist Therapeutics Rusfertide EHA Congress

Accesswire

Published on 07/03/2026 at 23:00, 1 day 22 hours ago

Eagle Plains Partner Refined Energy Announces Final Results for Winter 2026 Drill Program at Dufferin West
Published on 07/03/2026 at 23:00, 1 day 22 hours ago

Medicure Announces CFO Change
Published on 07/03/2026 at 21:28, 1 day 23 hours ago

Trifecta Gold Announces Closing of $1.66 Million Private Placement
Published on 07/03/2026 at 19:30, 2 days 1 hour ago

Polaris Renewable Energy Announces Q2 2026 Investor Call Details
Published on 07/03/2026 at 13:30, 2 days 7 hours ago

Nextech3D.ai Unveils Strategic AI Growth Roadmap Focused on Workforce Intelligence and Event Technology Innovation

View all ACCESSWIRE

EQS Group

Published on 07/05/2026 at 13:45, 7 hours 20 minutes ago

XPPen renforce son engagement en faveur de l’animation grâce à son partenariat avec la Résidence du Festival d’Annecy 2026 et sa présence au MIFA
Published on 07/05/2026 at 13:45, 7 hours 20 minutes ago

XPPen Strengthens Its Commitment to Animation with 2026 Annecy Festival Residency Partnership and MIFA Showcase
Published on 07/04/2026 at 17:35, 1 day 3 hours ago

Vantage Introduces 24/7 Gold CFD Trading with XAUUSD247
Published on 07/04/2026 at 11:01, 1 day 10 hours ago

EQS-Adhoc: Continental AG: Continental AG Sells ContiTech Group Sector
Published on 07/04/2026 at 09:05, 1 day 12 hours ago

Velo x McLaren Mastercard Formula 1® Team Relaunches Live Your Fandom to Bring Fans Closer to the Sport They Love

Les Echos

Published on 07/03/2026 at 21:49, 1 day 23 hours ago

Safran annonce la fin des négociations concernant le projet d'acquisition d’Exail Technologies.
Published on 07/03/2026 at 21:49, 1 day 23 hours ago

Safran announces the end of negotiations regarding the contemplated acquisition of Exail Technologies.
Published on 07/03/2026 at 18:42, 2 days 2 hours ago

Total number of voting rights and shares making up the share capital at June 30, 2026
Published on 07/03/2026 at 18:42, 2 days 2 hours ago

Capital et droits de vote au 30 juin 2026
Published on 07/03/2026 at 18:36, 2 days 2 hours ago

Disclosure of transactions in own shares from July 1 to July 3, 2026

View all LES ECHOS COMFI WIRE